Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc0501 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
KLM1-R |
LY294002 |
Unresolved |
4.0 |
28000865
|
acc0502 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
PK59 |
LY294002 |
Unresolved |
4.0 |
28000865
|
acc0503 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
KLM1-R |
Gemcitabine |
Negative |
5.0 |
28000865
|
acc0504 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
PK59 |
Gemcitabine |
Negative |
5.0 |
28000865
|
acc0505 |
STAT1 |
phosphorylation |
Ser727 |
human |
Ovarian Cancer |
TOV112D |
Bortezomib |
Negative |
5.0 |
23449448
|
acc0506 |
STAT1 |
phosphorylation |
Tyr701 |
human |
Ovarian Cancer |
TOV112D |
Bortezomib |
Negative |
5.0 |
23449448
|
acc0507 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3 |
Cisplatin |
Negative |
5.0 |
28685895
|
acc0508 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
A2780 |
Cisplatin |
Negative |
5.0 |
28685895
|
acc0509 |
VEGFR2 |
phosphorylation |
Tyr1175 |
human |
Bladder Cancer |
T24 |
AE-AS |
Unresolved |
4.0 |
28710377
|
acc0510 |
Chk1 |
phosphorylation |
Ser345 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Gemcitabine |
Negative |
5.0 |
29048622
|
acc0511 |
Smad2 |
phosphorylation |
Ser465 |
human |
Breast Cancer |
MDA-MB-231 |
Nafamostat mesilate |
Unresolved |
4.0 |
29196918
|
acc0512 |
Smad2 |
phosphorylation |
Ser467 |
human |
Breast Cancer |
MDA-MB-231 |
Nafamostat mesilate |
Unresolved |
4.0 |
29196918
|
acc0513 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Breast Cancer |
MDA-MB-231 |
NM |
Unresolved |
4.0 |
29196918
|
acc0514 |
DNMT1 |
ubiquitination |
unclear |
human |
Colorectal Cancer |
HCT-8-7T |
Alisertib |
Unresolved |
4.0 |
34522170
|
acc0515 |
DNMT1 |
ubiquitination |
unclear |
human |
Colorectal Cancer |
HCT-8-9T |
Alisertib |
Unresolved |
4.0 |
34522170
|
acc0516 |
STAT1 |
ubiquitination |
Tyr701 |
human |
Colorectal Cancer |
HCT-8-7T |
Alisertib |
Negative |
5.0 |
34522170
|
acc0517 |
STAT1 |
ubiquitination |
Tyr701 |
human |
Colorectal Cancer |
HCT-8-9T |
Alisertib |
Negative |
5.0 |
34522170
|
acc0518 |
beta-catenin |
phosphorylation |
Ser45 |
human |
Thyroid Cancer |
SW1736 |
I131 |
Negative |
4.5 |
29344218
|
acc0519 |
beta-catenin |
phosphorylation |
Tyr654 |
human |
Thyroid Cancer |
SW1736 |
I131 |
Negative |
4.5 |
29344218
|
acc0520 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Thyroid Cancer |
SW1736 |
I131 |
Negative |
4.5 |
29344218
|
acc0521 |
ERK1 |
phosphorylation |
Thr202 |
human |
Leukemia |
|
Trametinib |
Unresolved |
4.0 |
29419436
|
acc0522 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Leukemia |
|
Trametinib |
Unresolved |
4.0 |
29419436
|
acc0523 |
ERK2 |
phosphorylation |
Thr185 |
human |
Leukemia |
|
Trametinib |
Unresolved |
4.0 |
29419436
|
acc0524 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Leukemia |
|
Trametinib |
Unresolved |
4.0 |
29419436
|
acc0525 |
GFAT1 |
phosphorylation |
Ser243 |
human |
Pancreas Cancer |
MIA PaCa-2 |
2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0526 |
AMPK |
phosphorylation |
Thr172 |
human |
Pancreas Cancer |
MIA PaCa-2 |
2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0527 |
AMPK |
phosphorylation |
Thr183 |
human |
Pancreas Cancer |
MIA PaCa-2 |
2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0528 |
GFAT1 |
phosphorylation |
Ser243 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Met + 2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0529 |
AMPK |
phosphorylation |
Thr172 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Met + 2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0530 |
AMPK |
phosphorylation |
Thr183 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Met + 2-Deoxy-d-glucose |
Unresolved |
4.0 |
29753740
|
acc0531 |
ERK1 |
phosphorylation |
Thr202 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0532 |
ERK1 |
phosphorylation |
Tyr204 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0533 |
ERK2 |
phosphorylation |
Thr185 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0534 |
ERK2 |
phosphorylation |
Tyr187 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0535 |
Smad2 |
phosphorylation |
Ser465 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0536 |
Smad2 |
phosphorylation |
Ser467 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0537 |
Smad3 |
phosphorylation |
Ser423 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0538 |
Smad3 |
phosphorylation |
Ser425 |
rat |
Pituitary Tumor |
GH3 |
Trastuzumab + TGFB1 |
Unresolved |
4.0 |
29875136
|
acc0539 |
Smad2 |
phosphorylation |
Thr8 |
human |
Pancreas Cancer |
BxPC-3 |
Metformin |
Unresolved |
4.0 |
29956804
|
acc0540 |
Smad2 |
phosphorylation |
Thr8 |
human |
Pancreas Cancer |
PANC-1 |
Metformin |
Unresolved |
4.0 |
29956804
|
acc0541 |
Smad3 |
phosphorylation |
Thr8 |
human |
Pancreas Cancer |
BxPC-3 |
Metformin |
Unresolved |
4.0 |
29956804
|
acc0542 |
Smad3 |
phosphorylation |
Thr8 |
human |
Pancreas Cancer |
PANC-1 |
Metformin |
Unresolved |
4.0 |
29956804
|
acc0543 |
HK-2 |
phosphorylation |
Ser473 |
human |
Hepatocellular Carcinoma |
HepG2 |
Limonin |
Unresolved |
4.0 |
30013360
|
acc0544 |
STAT1 |
phosphorylation |
Ser727 |
human |
Pancreas Cancer |
L3.6pl |
EGFRBi armed ATC |
Unresolved |
4.0 |
23185240
|
acc0545 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
L3.6pl |
EGFRBi armed ATC |
Unresolved |
4.0 |
23185240
|
acc0546 |
CREB |
phosphorylation |
Ser133 |
human |
Ovarian Cancer |
OVCAR-3 |
Roflumilast |
Positive |
5.0 |
30069985
|
acc0547 |
CREB |
phosphorylation |
Ser133 |
human |
Ovarian Cancer |
SK-OV-3 |
Roflumilast |
Positive |
5.0 |
30069985
|
acc0548 |
MAP4 |
phosphorylation |
Ser696 |
human |
Ovarian Cancer |
HeyA8 |
Paclitaxel |
Negative |
5.0 |
30084832
|
acc0549 |
MAP4 |
phosphorylation |
Ser696 |
human |
Ovarian Cancer |
OVCAR5 |
Paclitaxel |
Negative |
5.0 |
30084832
|
acc0550 |
FAK |
phosphorylation |
Tyr397 |
human |
Gastric Cancer |
GIST882 |
Imatinib |
Negative |
5.0 |
30149002
|